Surface modification of functional nanoparticles for controlled drug delivery

Journal of Dispersion Science and Technology

Volumn 24, Issue 3-4, 2003, Pages 475-487

  Choi, Sung Wook ^a   Kim, Woo Sik ^a   Kim, Jung Hyun ^a  

^a Yonsei University   (South Korea)

Author keywords

Functional ligand; Long circulation; Nanoparticle; Oral delivery; Site specific delivery; Surface modification

Indexed keywords

BODY FLUIDS; CONTROLLED DRUG DELIVERY; HYDROPHILICITY; NANOSTRUCTURED MATERIALS;

SITE-SPECIFIC DEVLIVERY;

SURFACE TREATMENT;

MEDICAL APPLICATION;

EID: 0042236981     PISSN: 01932691     EISSN: None     Source Type: Journal    
DOI: 10.1081/DIS-120021803     Document Type: Article

References (67)

1. Cammas, S.; Suzuki, K.; Sone, C.; Sakurai, Y.; Kataoka, K.; Okano, T. Thermo-responsive polymer nanoparticles with a core-shell micelle structure as site-specific drug carriers. J. Control. Release 1997, 48, 157-164.
2. Löbenberg, R.; Araujo, L.; Briesen, H.V.; Rodgers; Kreuter, J. Body distribution of azidothymidine bound to hexyl-cyanoacrylate nanoparticles after i.v. injection to rats. J. Control. Release 1998, 50, 21-30.
3. Dunn, S.E.; Brindley, A.; Davis, S.S.; Davies, M.C.; Illum, L. Polystyrene-poly(ethylene glycol) (PS-PEG2000) particles as model system for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution. Pharm. Res. 1994, 11, 1016-1022.
4. Stolnik, S.; Illum, L.; Davis, S.S. Long circulation microparticulate drug carriers. Adv. Drug Deliv. Rev. 1995, 16, 195-214.
5. Hans, M.L.; Lowman, A.M. Biodegradable nanoparticles for drug delivery and targeting. Curr. Opin. Solid St. M. 2002, 6, 319-327.
6. Soppimath, K.S.; Aminabhavi, T.M.; Kulkarni, A.R.; Rudzinski, W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 2001, 70, 1-20.
7. Leroux, J.C.; Allèmann, E.; Jaeghere, F.D.; Doelker, E.; Gurny, R. Biodegradable nanoparticles from sustained release formulations to improved site-specific drug delivery. J. Control. Release 1996, 39, 339-350.
8. Redhead, H.M.; Davis, S.S.; Illum, L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characteristics and in vivo evalution. J. Control. Release 2001, 70, 353-363.
9. Peracchia, M.T.; Fattal, E.; Desmaële, D.; Besnard, M.; Noël, J.P.; Gomis, J.M.; Appel, M.; Angelo, J.; Couvreur, P. Stealth® PEGylated poly-cyanocarylate nanoparticles for intravenous administration and splenic targeting. J. Control. Release 1999, 60, 121-128.
10. Nakada, Y.; Tudomi, R.; Sakurai, K.; Takahashi, Y. Evaluation of long-circulating nanoparticles using biodegradable ABA triblock copolymers containing of poly(L-lactic acid) A-blocks attached to central poly(oxyethylene) B-blocks in vivo. Int. J. Pharm. 1998, 175, 109-117.
11. Rösler, A.; Vandermeulen, G.W.M.; Klok, H.A. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv. Drug Deliv. Rev. 2001, 53, 95-108.
12. Lavasanifar, A.; Samuel, J.; Kwon, G.S. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. Adv. Drug Deliv. Rev. 2002, 54, 169-190.
13. Kim, I.S.; Kim, S.H. Evaluation of polymeric nanoparticles composed of cholic acid and methoxy poly(ethylene glycol). Int. J. Pharm. 2001, 226, 23-29.
14. Oh, J.E.; Nam, Y.S.; Lee, K.H.; Park, T.G. Conjugation of drug to poly(D,L-lactic-co-glycolic acid) for controlled release from biodegradable microspheres. J. Control. Release 1999, 57, 269-280.
15. Tobio, M.; Sànchez, A.; Vila, A.; Soriano, I.; Evora, C.; Vila-Jato, J.L.; Alonso, M.J. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloid. Surf. B 2000, 18, 315-323.
16. Gref, R.; Lück, M.; Quellec, P.; Marchand, M.; Dellacherie, E.; Harnisch, S.; Blunk, T.; Müller, R.H. Stealth corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloid. Surf. B 2000, 18, 301-313.
17. Yasugi, K.; Nakamura, T.; Nagasaki, Y.; Kato, M.; Kataoka, K. Sugar-installed polymer micelles: synthesis and micellization of poly(ethylene glycol)-poly(D,L-lactide) block copolymers having sugar groups at the PEG chain end. Macromolecules 1999, 32, 8024-8032.
18. Kawashima, Y.; Yamamoto, H.; Takeuchi, H.; Kuno, Y. Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm. Dev. Technol. 2000, 5, 77-85.
19. Kreuter, J.; Alyautdin, R.N.; Kharlevich, D.A.; Ivanov, A.A. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res. 1995, 674, 171-174.
20. Hillery, A.M.; Jani, P.U.; Florence, A.T. Comparative, quantitative study of lymphoid and non-lymphoid uptake of 60 nm polystyrene particles. J. Drug Target. 1994, 2, 151-161.
21. Stella, B.; Arpicco, S.; Peracchia, M.T.; Desmaele, D.; Hoebeke, J.; Renoir, M.; D'Angelo, J.; Cattel, L.; Couvreur, P. Design of folic acid-conjugated nanoparticles for drug targeting. J. Pharm. Sci. 2000, 89, 1452-1464.
22. Montisci, M.J.; Giovannuci, G.; Duchêne, D.; Ponchel, G. Covalent coupling of asparagus pea and tomato lectins to poly(lactide) microspheres. Int. J. Pharm. 2001, 215, 153-161.
23. Ezpeleta, I.; Irche, J.M.; Stainmesse, S.; Chabenat, C.; Gueguen, J.; Orecchioni, A.M. Preparation of lectin-vicilin nanoparticles conjugates using the carbodiimide coupling technique. Int. J. Pharm. 1996, 142, 227-233.
24. Russell-Jones, G.J.; Arthur, L.; Walker, H. Vitamin B12-mediated transport of nanoparticles across Caco-2 cells. Int. J. Pharm. 1999, 179, 247-255.
25. Eniola, A.O.; Rodgers, S.D.; Hammer, D.A. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. Biomaterials 2002, 23, 2167-2177.
26. Yamamoto, Y.; Nagasaki, Y.; Kato, M.; Kataoka, K. Surface charge modulation of poly(ethylene glycol)- poly(D,L-lactide) block copolymer micelles: conjugation of charged peptides. Colloid. Surf. B 1999, 16, 135-146.
27. Zhang, Y.; Kohler, N.; Zhang, M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002, 23, 1553-1561.
28. Aksoy, S.; Tumturk H.; Hasirci, N. Stability of α-amylase immobilized on poly(methyl methacrylate-acrylic acid) microspheres. J. Biotechnol. 1998, 60, 37-46.
29. Dawson, G.F.; Halbert, G.W. The in vitro cell association of invasin coated polylactide-co-glycolide nanoparticles. Pharm. Res. 2000, 17, 1420-1425.
30. Yoo, H.S.; Park, T.G. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J. Control. Release 2001, 70, 63-70.
31. Kim, I.S.; Kim, S.H. Evaluation of polymeric nanoparticles composed of cholic acid and methoxy poly(ethylene glycol). Int. J. Pharm. 2001, 226, 23-29.
32. Kim, I.S.; Jeong, Y.I.; Cho, C.S.; Kim, S.H. Coreshell type polymeric nanoparticles composed of poly(L-lactic acid) and poly(N-isopropylacrylamide). Int. J. Pharm. 2000, 211, 1-8.
33. Andrade, J.D.; Hlady, V.; Jeon, S.I. Poly(ethylene oxide) and protein resistance-principles, problems, and possibilities. Adv. Chem. Ser. 1996, 248, 51-59.
34. Storm, G.; Belliot, S.O.; Daemen, T.; Lasic, D.D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv. Drug Deliv. Rev. 1995, 17, 31-48.
35. Illum, L.; Davis, S.S. Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration. J. Pharm. Sci. 1983, 72, 1086-1089.
36. Illum, L.; Davis, S.S. The organ uptake of intravenously administrated colloidal particles can be altered using a non-ionic surfactant (poloxamer 338). FEBS Letts. 1984, 167, 79-82.
37. Li, Y.P.; Pei, Y.Y.; Zhang, X.Y.; Gu, Z.H.; Zhou, Z.H.; Yuan, W.F.; Zhou, J.J.; Zhu, J.H.; Gao, X.J. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J. Control. Release 2001, 71, 203-211.
38. Hobson, B.; Denekamp, J. Endothelial proliferation in tumors and normal tissues: continuous labeling studies. Br. J. Cancer 1984, 49, 405-413.
39. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv. Enzyme Regul. 2001, 41, 189-207.
40. Yuan, F.; Dellian, M.; Fukumura, D.; Leunig, M.; Berk, D.A.; Torchilin, V.P.; Jain, R.K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995, 55, 3752-3756.
41. Yokoyama, M.; Okano, T.; Sakurai, Y.; Fukushima, S.; Okamoto, K.; Kataoka, K. Selective delivery of adriamycin to a solid tumor using a polymeric micelle carrier system. J. Drug Target. 1999, 7, 171-186.
42. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 2000, 65, 271-284.
43. Nakanishi, T.; Fukushima, F.; Okamoto, K.; Suzuki, M.; Matsumura, Y.; Yokoyama, M.; Okano, T.; Sakurai, Y.; Kataoka, K. Development of the polymer micelle carrier system for doxorubicin. J. Control. Release 2001, 74, 295-302.
44. Peracchia, M.T.; Fattal, E.; Desmaeële, D.; Besnard, M.; Noël, J.P.; Gomis, J.M.; Appel, M.; d'Angelo, J.; Couvreur, P. Stealth PEGylated poly-cyanoacrylate nanoparticles for intravenous administration and splenic targeting. J. Control. Release 1999, 60, 121-128.
45. Gijsens, A.; Derycke, A.; Missiaen, L.; De Vos, D.; Huwyler, J.; Eberle, A.; de Witte, P. Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes. Int. J. Cancer 2002, 101, 78-85.
46. Dan, N. Effect of liposome charge and PEG polymer layer thickness on cell-liposome electrostatic interactions. Biochim. Biophys. Acta (BBA)-Biomembranes 2002, 31, 343-348.
47. Behrens, I.; Pena, A.I.V.; Alonso, M.J.; Kissel, T. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm. Res. 2002, 19, 1185-1193.
48. Ramge, P.; Unger, R.E.; Oltrogge, J.B.; Zenker, D.; Begley, D.; Kreuter, J.; Von Briesen, B. Polysorbate-80 coating enhances uptake of polybutylcyanoacrylate (PBCA)-nanoparticles by human and bovine primary brain capillary endothelial cells. Eur. J. Neurosci. 2000, 12, 1931-1940.
49. Cho, C.S.; Kobayashi, A.; Takei, R.; Ishihara, T.; Maruyama, A.; Akaike, T. Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers. Bio-materials 2001, 22, 45-51.
50. Cho, C.S.; Cho, K.Y.; Park, I.K.; Kim, S.H.; Sasagawa, T.; Uchiyama, M.; Akaike, T. Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly(L-lactic acid) nanoparticles coated with galactose-carrying polystyrene. J. Control. Release 2001, 77, 7-15.
51. Dwek, R.A. Glycobiology: toward understanding the function of sugars. Chem. Rev. 1996, 96, 683-720.
52. O'Hagan, D.T. Microparticles as oral vaccines. In Novel Delivery Systems for Oral Vaccines; O'Hagan, D.T., Ed.; CRC Press, Inc.: Boca Raton, Florida, 1994; 175-205.
53. LeFevre, M.E.; Joel, D.D. Distribution of label after intragastric administration of 7BE-labeled carbon to weaning and aged mice. Pro. Soc. Exp. Biol. Med. 1986, 182, 112-119.
54. LeFevre, M.E.; Boccio, A.M.; Joel, D.D. Instestinal uptake of fluorescent microspheres in young and aged mice. Pro. Soc. Exp. Biol. Med. 1989, 190, 23-27.
55. Russell-Jones, G.J.; Veitch, H.; Arthur, L. Lectin-mediated transport of nanoparticles across Caco-2 and OK cells. Int. J. Pharm. 1999, 190, 165-174.
56. Desai, M.P.; Labhasetwar, V.; Amidon, G.L.; Levy, R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm. Res. 1996, 13, 1838-1845.
57. Eldridge, J.H.; Hammond, C.J.; Meulbroek, J.A.; Staas, J.K.; Gilley, R.M.; Tice, T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administrated biodegradable microspheres target the Peyer's patches. J. Control. Release 1990, II, 205-214.
58. Jani, P.; Halbert, G.W.; Langridge, J.; Florence, T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 1989, 41, 809-812.
59. Jani, P.; Halbert, G.W.; Langridge, J.; Florence, A.T. Nanoparticle uptake by the rat gastro-intestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 1990, 42, 821-826.
60. Florence, A.T.; Sakthivel, T.; Toth, I. Oral uptake and traslocation of a polylysine dendrimer with a lipid surface. J. Control. Release 2000, 65, 253-259.
61. Tobio, M.; Sánchez, A.; Vila, A.; Soriano, I.; Evora, C.; Vila-Jato, J.L.; Alonso, M.J. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloid. Surf. B 2000, 18, 315-323.
62. Florence, A.T.; Hussain, N. Tanscytosis of nanoparticles and dendrimer delivery systems: evolving vistas. Adv. Drug Deliv. Rev. 2001, 50, S69-S89.
63. Pappo, J. Generation and characterization of monoclonal antibodies recognizing follicle epithelial M cells in rabbit gut-associated lymphoid tissues. Cell. Immunol. 1989, 120, 31-41.
64. Isberg, R.R.; Vannhieu, G.T. Two mammalian-cell internalization strategies used by pathogenic bacteria. Ann. Rev. Genetics 1994, 28, 395-422.
65. Lelouard, H.; Reggio, H.; Mangeat, P.; Neutra, M.; Montcourrier, P. Mucin-related epitopes distinguish M cells and enterocytes in rabbit appendix and Peyer's patches. Infect. Immun. 1999, 67, 357-367.
66. Smith, M.W.; Tomas, N.W.; Jenkins, P.G.; Miller, N.G.A.; Cremaschi, D.; Porta, C. Selective transport of microparticles across Peyer's patch follicle-associated M cells from mice and rats. Exp. Physiol. 1995, 80, 735-743.
67. Takeuchi, H.; Yamamoto, H.; Kawashima, Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 2001, 47, 39-54.